Singapore, April 14, 2008: ChemGenex Pharmaceuticals, a pharmaceutical development company dedicated to improving the lives of patients by developing personalized oncology medicines from Australia has appointed Ms Luana Staiger as Vice President of Regulatory Affairs. Ms Staiger will oversee ChemGenex’s global regulatory development plans and be responsible for the company's regulatory submissions.

 

Ms Staiger has been working in the pharmaceutical and biotechnology industry for over 20 years, and has significant experience in regulatory affairs, quality assurance, and project management. Ms Staiger’s experience in regulatory affairs management and product submissions with both the U.S. FDA and European regulatory authorities will be invaluable to the company over the coming year, according to an official release.